Skip to main content
Retour
LBRX logo

LB Pharmaceuticals Inc Common Stock

Qualité des données : 100%
LBRX
NASDAQ Healthcare Biotechnology
23,67 €
▲ 0,14 € (0,60%)
Cap. Boursière : 598,83M
Fourchette du Jour
23,48 € 24,47 €
Fourchette 52 Semaines
13,36 € 27,55 €
Volume
113 426
Moyenne 50J / 200J
23,15 € / 19,54 €
Clôture Précédente
23,53 €

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (626 pairs)

Métrique Action Médiane du Secteur
P/E -9,5 0,4
P/B 2,9
ROE % 3,8
Net Margin % 3,9
Rev Growth 5Y % 10,0
D/E 0,2

Points Clés

Negative free cash flow of -53,82M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Sécurité

Debt / Equity
N/A
Current Ratio3,56
Interest Coverage0,00

Valorisation

P/E Ratio
-9,49
P/B RatioN/A
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -63,10M
ROE N/A ROA -188,17%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -53,82M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 3,56
Interest Coverage 0,00 Dividend Yield 0,00%
Valuation
P/E Ratio -9,49 P/B Ratio N/A
P/S Ratio N/A PEG Ratio 0,00
EV/EBITDA N/A Dividend Yield 0,00%
Market Cap 598,83M Enterprise Value 579,55M

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2024 FY2023 FY2022
Revenue 0,0 0,0 0,0
Net Income -63,10M -6,28M -14,35M
EPS (Diluted) -17,83 -1,77 -4,05
Gross Profit 0,0 0,0 0,0
Operating Income -64,83M -11,38M -2,81M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2024 FY2023 FY2022
Total Assets 33,53M 45,66M 21,49M
Total Liabilities 128,09M 80,13M 50,30M
Shareholders' Equity -94,55M -34,47M -28,81M
Total Debt 3,70M 0,0 24,15M
Cash & Equivalents 22,98M 14,98M 21,40M
Current Assets 28,88M 45,63M 21,49M
Current Liabilities 8,11M 2,61M 469 000,0